Stoke Therapeutics
STOK
26.81
-0.12
-0.45%
Stoke Therapeutics
US · STOK
#2942 by market cap
Listed 2019
26.81
-0.12
-0.45%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About Stoke Therapeutics
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.
- Founded
- 2014
- CEO
- Mr. Ian F. Smith
- Employees
- 170
- Headquarters
- Bedford, Massachusetts, United States of America
- Fiscal year end
- 12-31
- Website
- stoketherapeutics.com
Company profile
- Exchange
- US
- Symbol
- STOK
- Market-cap rank
- #2942
- Listing date
- 2019-06-19
- Market cap
- 1.75B
- Float cap
- 1.34B
- Shares out
- 65.41M
- Float shares
- 49.92M
Sectors & themes
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Stoke Therapeutics discussion 0 comments